Stock-Based Compensation

3 Months Ended

Mar. 31, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

The Company classifies stock-based compensation expense in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss, based on the department to which the recipient belongs. Stock-based compensation expense included in cost of goods sold and operating expenses during the three months ended March 31, 2017 and 2016, was as follows:



	Three Months Ended
	March 31,
	2017		2016
Cost of goods sold	$	169	$	273
Operating expenses:
Research and development	260		363
Clinical and regulatory affairs	260		(100		)
Marketing and sales	1,058		1,130
General and administrative	1,207		1,216
Total operating expenses	$	2,785	$	2,609
Total	$	2,954	$	2,882

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details